Skip to main content
OpenTrials
Completed

NCT Number: NCT06228131

Detection of hCG in Early Pregnancy Clinical Samples

To evaluate the detection of hCG in the early pregnancy urine samples by Human chorionic gonadotropin (HCG) test system.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–55 year

Sex eligibility

Female

Study type

Observational

Primary location

First Teaching hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female;
  • 18-55 years of age;
  • In a state of preparing for pregnancy;
  • Voluntary and sign informed consent form.

Exclusion criteria

  • Within 8 weeks of childbirth or abortion;
  • The investigator has reason to believe that it is inappropriate for subjects to participate in the study.

Treatment and study plan

Primary outcomes

  1. To evaluate the detection of hCG in the early pregnancy urine samples by investigational device.

    Time frame: 10day

    Percentage Pregnancy Results (%) for early pregnancy urine samples on different days from day -8 to day +1 relative to the expected period.

    Percentage Pregnancy Results (%): 79% (day -5 relative to the expected period)

Sponsors and collaborators

Lead sponsor

Andon Health Co., Ltd

Industry

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 29, 2024
Registry last updated
Jan 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.